for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Ranbaxy says gets US nod for blood pressure drug

NEW DELHI, March 5 (Reuters) - India's Ranbaxy Laboratories RANB.BO said on Thursday it had received the U.S. Food and Drug Administration's approval to make and sell blood pressure drug Quinaprilt Hydrochloride and Hydrochlorothiazide, a bioequivalent of Pfizer's PFE.N Accuretic tablets.

Ranbaxy said in a statement it had got approvals for the 10/12.5 mg, 20/12.5 mg and 20/25 mg versions of the drug.

It said the application had been submitted from its OHM Laboratories facility in New Jersey. (Reporting by Devidutta Tripathy, Editing by Mark Williams

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up